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Research, University of Michigan Medical School, Ann Arbor, MichiganABSTRACT Conformational diseases result from the failure of a specific protein to fold into its correct functional state. The
misfolded proteins can lead to the toxic aggregation of proteins. Protein misfolding in conformational diseases often displays
a threshold behavior characterized by a sudden shift between nontoxic to toxic levels of misfolded proteins. In some conforma-
tional diseases, evidence suggests that misfolded proteins interact with bystander proteins (unfolded and native folded proteins),
eliciting a misfolded phenotype. These bystander isomers would follow their normal physiological pathways in absence of mis-
folded proteins. In this article, we present a general mechanism of bystander and misfolded protein interaction which we have
used to investigate how the threshold behavior in protein misfolding is triggered in conformational diseases. Using a continuous
flow reactor model of the endoplasmic reticulum, we found that slight changes in the bystander protein residence time in the
endoplasmic reticulum or the ratio of basal misfolded to bystander protein inflow rates can trigger the threshold behavior in
protein misfolding. Our analysis reveals three mechanisms to rescue bystander proteins in conformational diseases. The results
of our model can now help direct experiments to understand the threshold behavior and develop therapeutic strategies targeting
the modulation of conformational diseases.INTRODUCTIONConformational diseases originate from the failure of
specific proteins to adopt or maintain their native conforma-
tional state (1). Misfolded proteins are implicated in the
reduction of native protein levels and the formation of aggre-
gates in a variety of conformational diseases, such as
b-amyloid toxicity, Charcot-Marie-Tooth, diabetes, prese-
nile dementia, and a1-antitrypsin deficiency with liver
disease (2). Proteins misfold due to cellular stress as well
as inherited or stochastic mutations (3). Evidence suggests
that misfolded proteins can interact with bystander isomers
to elicit a misfolded phenotype (4). A bystander protein is
one that, in the absence of misfolded proteins, will be routed
to its normal physiological pathway. The bystander protein
pool is composed of the unfolded isomers and native (folded)
proteins. In the presence of misfolded proteins, bystander
proteins misfold, resulting in decreased native protein levels
and increased levels of protein aggregation (4). This phenom-
enon has recently been characterized in the autosomal domi-
nant Mutant INS-gene Induced Diabetes of Youth (5–7).
The formation of misfolded proteins in conformational
diseases often displays a threshold behavior that is charac-
terized by a sudden shift in the concentration of proteins
from low misfolded concentration (nontoxic) to high mis-
folded concentration (toxic) levels. For example, an increase
in mutant type I collagen expression, above a critical
threshold, results in an aortic rupture due to a breakdown
in collagen formation (8). Vascular toxicity appears to occurSubmitted January 10, 2011, and accepted for publication March 14, 2011.
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0006-3495/11/04/1864/10 $2.00in a dose-dependent manner with b-amyloids, which are a
misfolded form of amyloid precursor protein and the main
component of aggregates found in patients with Alzheimer’s
disease (9). Both of these examples, and several others, are
the result of dominant negative mutations that give rise to
increased misfolded protein levels. Misfolded isomers exert
a dominant-negative effect (toxic gain-of-function) possibly
through an interaction with a protein-binding partner ex-
pressed in cells (2). A key to controlling conformational
diseases, therefore, is to understand the underlying mecha-
nisms responsible for threshold behavior under conditions
of increased protein misfolding.
The threshold behavior in conformational diseases can
arise from a sigmoidal dose-response curve or the appear-
ance of bistability within a certain range of parameters. In
dynamical and complex systems, bistability is characterized
by two steady states and a third unstable steady state
(10,11). Experimental evidence suggests that this threshold
phenomenon is associated with bistability; misfolded iso-
mer or aggregate protein concentration can exhibit bistabil-
ity with changes in temperature (12), pressure (13), and pH
(14). There is also evidence of guanidinium chloride con-
centration-dependent bistability in the transition between
unfolded and folded transthyretin protein states (15). To
date, there are few mathematical models which can describe
the threshold of protein misfolding or aggregation in confor-
mational diseases as a bistable system (16–19). Generaliza-
tions of the Smoluchowski’s theory of coagulation have
been applied to investigate protein polymerization and
aggregation (20). However, these models do not explain
the threshold for protein misfolding or aggregation in a
mechanistic manner (21).doi: 10.1016/j.bpj.2011.03.006
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FIGURE 1 Schematic diagram of a continuous flow reactor model of the
endoplasmic reticulum lumen (ER). In this model, the bystander protein
pool, composed of unfolded and folded isomers, has an inflow rate of
[N0]/tN, where [N0] is the basal bystander protein concentration and tN is
the bystander ER residence time. The misfolded protein has an inflow
rate equal to [M0]/tM, where [M0] is the basal misfolded protein concentra-
tion and tM is the misfolded ER residence time. Bystander and misfolded
proteins interact with reaction rate R([N],[M]), which is a function of the
bystander and misfolded protein concentrations. The outflow rate of
bystander and misfolded proteins follows first-order kinetics. The outflow
of isomers is driven by the ER-assisted folding (ERAF), ER-assisted degra-
dation (ERAD), protein export, and translocation pathways.
A Model of Threshold Behavior 1865The lackofmechanisticmodels in the literature is not unex-
pected, because experimental determination of protein mis-
folding or aggregation pathways is technically demanding
(22). A major difficultly lies in obtaining accurate character-
ization of the diverse, short-lived intermediate misfolded and
aggregate isomers that may occur during formation of both
polymorphous and highly structured aggregates (i.e., fibrils).
An alternative to focusing on themechanism ofmisfolding or
aggregation itself is to investigate the progression of cellular
dysfunction from the perspective of bystander protein
production. The bystander protein pool can be detected exper-
imentally through nonreducing Tris-Tricine-urea-SDS-
PAGE if the misfolded protein is the result of disulfide mis-
pairing (23–25). Loss-of-function diseases are characterized
by a reduction in native protein levels, which could be caused
by protein misfolding. Understanding the mechanisms that
deplete bystander protein levels will be important in the
search for therapeutic interventions aimed at controlling
conformational diseases.
In this article, we present a general model describing the
bystander protein disappearance (loss-of-function) through
direct or indirect interactionwithmisfoldedprotein to explore
threshold behavior in conformational diseases. Our model
also describes the production of misfolded isomers, which
makes it applicable to investigate toxic gain-of-function in
conformational diseases. We find that a mathematical formu-
lation of our model can exhibit the threshold behavior typi-
cally found in some conformational diseases. The threshold
behavior is explained by the appearance of bistability in our
mathematical model. Furthermore, we find that bistability is
a function of two parameters: the bystander isomer residence
time in the endoplasmic reticulum lumen, and the ratio of the
basal inflow rates of misfolded to bystander protein. We also
derive the necessary conditions for the manifestation of the
threshold behavior based on this ratio and the order of the
reaction with respect to the misfolded and bystander isomers.
After analyzing our model, we propose three mechanisms to
rescue bystander protein in conformational diseases. Our
results provide mechanistic insight into the threshold
behavior in conformational diseases and open potential ther-
apeutic avenues to regulate conformational diseases.MODEL
A model of bystander protein disappearance
in the presence of misfolded protein
We model the process of protein production and folding in the endoplasmic
reticulum (ER) lumen as occurring within a continuous flow reactor (see
Fig. 1). In our model, there is a continuous flow of the recently synthesized
conformational isomers, the bystander N and misfolded M proteins, which
is the direct result of basal protein synthesis and depletion (26,27). Under
normal conditions, bystander and misfolded proteins inflow with the
constant basal rates [N0]/tN and [M0]/tM, respectively. [N0] and [M0]
represent, respectively, the basal concentrations of bystander and misfolded
protein. The value ti is the ER residence time of isomer i. Bystander
unfolded isomers are depleted through the ER-assisted folding pathway,whereas the bystander folded protein is exported from the ER (28). On
the other hand, misfolded proteins are depleted from the ER, either through
ER-assisted degradation (3) or protein translocation (29). We assume that
the rate of these outflow processes is of first-order kinetics. Therefore,
the system of differential equations governing the bystander N and mis-
folded M isomer concentration in the ER lumen is
d½N
dt
¼ ½N0  ½N
tN
 Rð½N; ½MÞ; (1)
d½M
dt
¼ ½M0  ½M
tM
þ Rð½N; ½MÞ; (2)
where R([N],[M]) is the reaction rate between bystander and misfolded
proteins. Note that we are denoting concentration with square brackets.
In the next subsection, we discuss the determination of the reaction rate
R([N],[M]) between the bystander and misfolded proteins.A general mechanism of bystander and misfolded
protein interaction in conformational diseases
The irreversible aggregation typical of conformational diseases is highly
sensitive to protein conformation. The misfolded protein pool (M) encom-
passes nonnative denatured and misfolded isomers. This pool is aggrega-
tion-prone due to the exposure of hydrophobic groups and disulfide
bonds, which can result in strong, and irreversible protein-protein contacts
(30,31). Therefore, there is compelling biochemical evidence suggesting
that the misfolded isoforms are responsible for the onset of certain confor-
mational diseases (32).
Protein aggregation is initiated by the reversible aggregation of misfolded
isomers, M, followed by structural rearrangements. These rearrangements
lead to the formation of an intermediate committed to the aggregation
pathway (32,33). Protein aggregation proceeds as more misfolded isomers
are committed to the aggregation pathway (34). There are two sources of
misfolded isomers. Misfolded isomers M are formed by the spontaneous
and first-order conversion of bystander isomers, N (32,35). This conversion
is sporadic and represents a minor source of misfolded protein formation in
conformational diseases. The main source of misfolded isoform M is the
conversion of bystander protein N into a misfolded isoform M through
process catalyzed by M (32,36). This process can be represented by a
phenomenological reaction rate of the formBiophysical Journal 100(8) 1864–1873
1866 Sandefur and SchnellRð½N; ½MÞ ¼ k½Nn½Mm: (3)
In the above equations, the exponents n and m specify the order of the reac-
tion with respect to the bystander and misfolded proteins, respectively. The
parameter k is a rate constant of order (nþm). Note that nR1 and mR1.
Note that the reactor (Eqs. 1-2) and rate (Eq. 3) are a general case of the
cubic autocatalysis reactor (10).
The (nþm)th order of our phenomenological rate Eq. 3 does not imply
that we are proposing a single, multimolecular, elementary step. There
are multiple combinations of bimolecular steps that, when combined,
give an overall reaction rate with this (nþm)th order form. For example,
we can consider the scenario in which aggregation of misfolded isomers
M follows an association-limited aggregation mechanism (33). The conver-
sion of bystander N into misfolded isomer M involves a two-step mecha-
nism involving an aggregate intermediate A:
M þM#k1
k1
A; (4)
N þ A/k2 M þ A: (5)
In this mechanism, two misfolded isomers form a dimer, which then plays
the catalytic role to convert the bystander into a misfolded isomer. If the
reverse reaction constant of the dimerization is higher than the forward
reaction constants, k1[ k1 and k1[ k2, then the dimerization step
Eq. 4 is rate-limiting for the formation of the smallest aggregate (37,38),
and the overall rate of disappearance of the bystander isomer N will be
Eq. 3 with n ¼1 and m ¼ 2.Bystander isomer concentration at steady state
We can understand the reaction dynamics by studying the steady states. At
the steady state, Eqs. 1 and 2 are
d½N
dt
¼ ½N0  ½N
tN
 Rð½N; ½MÞ ¼ 0; (6)
d½M
dt
¼ ½M0  ½M
tM
þ Rð½N; ½MÞ ¼ 0: (7)
By adding Eqs. 6 and 7, the ER reactor model has the steady-state relation-
ship of
½N0
tN
þ ½M0
tM
¼ ½N
tN
þ ½M
tM
: (8)
We now can derive an expression for the bystander isomer concentration at
steady state. Using the steady-state relationship Eq. 8 and phenomenolog-
ical reaction rate Eq. 3, we can uncouple Eqs. 6 and 7. This yields an expres-
sion for the bystander isomer concentration at the steady state of the form
½N0  ½N
tN
 kNn

tM
tN
ð½N0  ½NÞ þ ½M0
m
¼ 0: (9)
Beforewe can analyze ourmodel, we derive a suitable dimensionless form of
Eq. 9. The nondimensionalization allows us to reduce the number of param-
eters in ourmodel and give an absolutemeasure of themodel parameters inde-
pendent of units ofmeasurement. By using Segel (39) concepts of scaling, we
scale the bystander isomer concentration [N] with a parameter that provides
an estimate of its maximum value. We choose the dimensionless variable:
u ¼ ½N½N0: (10)Biophysical Journal 100(8) 1864–1873Substituting Eq. 10 into Eq. 9 and rearranging, we obtain the dimensionless
equation for the bystander isomer concentration at steady state,
1 u
tu
 un½trð1 uÞ þ qm¼ 0; (11)
with the nondimensional parameters defined as
tu ¼ ktN½N0ðnþm1Þ;
tr ¼ tM
tN
; and
q ¼ ½M0½N0:
(12)
In Eq. 11, tu is the bystander isomer dimensionless residence time in the
ER, tr is the ratio of the misfolded to bystander isomers residence times,
and q is the ratio of the misfolded to bystander isomer initial concentrations.
There are limits to the values of our variable and some of our parameters.
The bystander isomer u lies in the range of
0%u%1: (13)
Under normal physiological conditions, the ratio of misfolded to bystander
isomer initial concentrations q lie in the range of
0%q  1; (14)
because misfolded isomers are usually in lower concentrations than the
bystander proteins. On the other hand, the ER residence time of misfolded
isomers is larger than the ER residence time of bystander isomers
(tM[ tN) (28); this implies that tr lies in the range of
tr[1: (15)
There are no bounds on tu.
Note that the misfolding reaction will be completed when the bystander
and misfolded isomers have reached steady state. Therefore, we can define
the extent of the reaction, x, as
x ¼ 1 u: (16)
At the beginning of the reaction, x ¼ 0. At the end of the reaction, the
bystander protein can be depleted to a low steady-state concentration or
the production of misfolded isomer can reach a high steady-state concentra-
tion. This makes our model applicable to investigate loss-of-function
disease due to bystander protein depletion or toxic gain-of-function due
to misfolded protein production. Substituting Eq. 16 into Eq. 11 yields an
expression for the rate of the extent of the reaction at steady state
yðxÞ ¼ t1u x|ﬄ{zﬄ}
yf ðxÞ
 ð1 xÞnðtrx þ qÞm|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
yrðxÞ
¼ 0: (17)
The above expression has two dimensionless rates: the reactor flow rate in
the ER, yf(x), and the reaction rate, yr(x). Our analysis will benefit from the
division of the model into these two rates, as will be evident in the next
section.RESULTS
The model can exhibit bistability
In our mathematical model, the extent of the reaction can
attain a value which balances the flow rate, yf (x), with the
reaction rate, yr(x). When this happens, the bystander isomer
and misfolded isomer concentrations are at steady state.
From Eq. 17, the steady states are given by the solutions
of the equation
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FIGURE 2 Steady states for the extent of the reaction from Eq. 17 as a
function of q. The steady states are given by the intersections of yf (x) and
yr(x). (A) Flow diagram illustrates the origins of bistability, which creates
a threshold behavior in the model. (B) Geometrical picture of the rate of the
reaction y(x). From the graph, we can determine all the steady states and their
stability. Themodel exhibits one, three, or again, one steady-state solutionas q
increases from q1 to q3, where q1 < q2 < q3. (Open circle) Unstable steady
state; (solid circles) stable steady states for q ¼ q2. Note that the model
exhibits bistability for q2. (Insets) Lower steady-state point. Parameter values
are n ¼ 2, m ¼ 4, tr ¼ 4, tu ¼ 0.1, q1 ¼ 0.05, q2 ¼ 0.5, and q3 ¼ 0.75.
A Model of Threshold Behavior 1867yf ðxÞ  yrðxÞ ¼ t1u x  ð1 xÞnðtrx þ qÞm¼ 0: (18)
This is a (nþm)th-order polynomial, meaning x can have up
to (nþm) steady states. We are only interested in the phys-
ically realistic solutions in the range x ¼ [0,1].
A convenient way to investigate the total number of
steady states is to find the intersections of yf(x) and yr(x)
in the flow diagram for different values of tu, tr, q, n, and
m. The flow rate yf (x) is a straight line with slope deter-
mined by tu. The reaction rate yr(x) is a higher-order poly-
nomial, which can potentially have (nþm) roots between
x ¼ [0,1]. Surprisingly, yr(x)has a simple concave down-
wards form between x ¼ ½0; 1Þ with a maximum at
x ¼ 1 nðtr þ qÞ=trðnþ mÞ
(see Appendix A). For a fixed value of tu, the flow rate yf(x)
will remain fixed in the flow diagram. Depending on the
values of tr, q, n, and m, the system can exhibit more than
one steady state.
An easy way of changing the number of steady states is to
vary the ratio of the misfolded to bystander isomer initial
concentrations (q), while keeping tr, n, and m constant.
Increasing q increases the maximum value of yr(x) without
affecting yf(x). The manner in which the steady states change
with q is illustrated in Fig. 2, showing three steady states at
intermediate values of q. The actual values of the steady states
are not important here. What is important, however, is the
existence of one, three, or again, one steady-state solution
as q increases from q1 to q3,where q1< q2< q3. By inspection,
x2 is linearly unstable, because vy(x)/vx> 0 at x¼ x2, while x1
and x3 are stable steady states, because at these points vy(x)/
vx < 0 (Fig. 2 B). The model, therefore, exhibits bistability
which creates the threshold behavior found in some confor-
mational diseases. A similar pattern in the change of steady
states can be observed for fixed tr, q, n, and m, and varying
the flow rate of the bystander isomer (tu) (Fig. 3).
The model can exhibit physically unrealistic steady states
if parameters are not appropriately bounded. We need to set
up limits for the critical point
x ¼ 1 nðtr þ qÞ=trðnþ mÞ;
where yr(x) achieves a maximum. Given that the extent of
the reaction x is bounded by 0 and 1, the critical point
may lie in the range
0 < 1 nðtr þ qÞ
trðnþ mÞ < 1: (19)
We find that the condition given by Eq. 19 is valid when
q
tr
<
m
n
: (20)
Note that q/tr is equivalent to the ratio of basal misfolded
isomer to bystander isomer inflow rates into the ER, which
we define asl ¼ q
tr
h
½M0=tM
½N0=tN : (21)
The parameter l plays an important role in the model, which
can be appreciated in Fig. 2. The variation of q is effectively
a variation of l as the value of tr remains constant. We also
further investigate the influence of l on the threshold
behavior in the sections below.Influence of tu and l on the threshold behavior
Now we investigate how the model jumps from one to three
steady states when the functions yf(x) and yr(x) become
tangential in the flow diagram (Fig. 2 A). The expressions
for the tangency of yf(x) and yr(x) allow us to determine
the parameters contributing to the threshold behavior.
In chemical reaction models, the tangency of curves in
flow diagrams and the appearance of more than one steady
state is relatively common. For tangency, our model requires
simultaneously that
yf ðxÞ ¼ yrðxÞ and y0f ðxÞ ¼ y0rðxÞ: (22)Biophysical Journal 100(8) 1864–1873
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FIGURE 3 Steady states of the model from Eq. 17 for changes in the
bystander isomer residence time in the ER (tu). (A) Steady states as the
intersections of yf(x) and yr(x). The flow diagram illustrates that bistability
can arise by increasing tu. The bistability explains the threshold behavior in
our model. For a fixed yr(x), the model is bistable when tu<tu<tuþ . (B)
Stationary steady-state locus in the bifurcation diagram as a function of
the bystander residence time tu. The bifurcation curve shows stable steady
states (solid lines) and unstable steady states (dashed line). The lower stable
steady-state branch is characterized by the fast flow of bystander isomers in
the ER. The higher stable steady-state branch is characterized by a high
bystander isomer depletion and high misfolded isomer production. Param-
eter values are n ¼ 1, m ¼ 2, tr ¼ 6, tu ¼ 0:10, tuþ ¼ 0:42, and q ¼ 0.1.
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t1u ¼ x1ð1 xÞnðtrx þ qÞm; (23)
t1 ¼ ½mt ð1 xÞ  nðt x þ qÞð1 xÞðn1Þðt x þ qÞðm1Þ:u r r r
(24)
Dividing the above equations and rearranging gives a
quadratic expression for the tangency points,
x5 ¼ ðm 1Þ  lðn 1Þ5
ﬃﬃﬃﬃ
D
p
2ðmþ n 1Þ ; (25)
where
D ¼ l2ðn 1Þ22lðnmþ nþ m 1Þ þ ðm 1Þ2: (26)
By examining Eqs. 25 and 26, we find that multiple intersec-
tions and tangencies are only possible if
nR1 and mR2: (27)
By using the above expressions, we can investigate the influ-
ence of the tu on the bistability, which creates the threshold
behavior in our model. Substituting Eq. 25 into Eq. 23, weBiophysical Journal 100(8) 1864–1873determine the critical bystander isomer dimensionless resi-
dence time points tuH for tangency in the flow diagram:
tuH ¼
x5
ð1 x5 Þnðtrx5 þ qÞm: (28)
In the flow diagram (Fig. 3 A), for a fixed yr, the family of
flow rates yf between the low flow rate yf ðx; tuþÞ and high
flow rate yf ðx; tuÞ exhibits three steady states: two stable
steady states and one unstable steady state. Therefore, the
model is bistable for tu<tu<tuþ. The reaction has a single
steady state for tu<tu or tu>tuþ.
The bifurcation diagram x versus tu (Fig. 3 B) has an
S-shaped curve. At short bystander residence time with
tu<tu , the reaction has only one steady state characterized
by low bystander isomer depletion and low misfolded
isomer production. As the bystander residence time
increases, but remains bounded by tu<tuþ, the bystander
isomer depletion increases slightly along a low bystander
isomer depletion steady-state branch. We call this the fast-
flow branch because it is characterized by the fast flow of
bystander isomers in the ER lumen, which decreases the
probability of misfolded isomers to react with the bystander
isomers. At a long bystander residence time tu>tuþ , the
reaction moves to a new steady-state branch characterized
by a high bystander isomer depletion and a high production
of misfolded isomer. We name this the outbreak-branch
because the conformational disease is manifested on this
branch.
Note that for tu<tu<tuþ the fast flow and outbreak
branches coexist. In the absence of perturbation, the system
will remain in one steady-state branch. For example, a sus-
tained and progressive increase in the bystander residence
time tu will cause a discontinuous change in the steady state
from the fast flow branch to the outbreak branch at tuþ . In
this case, tuþbecomes the threshold behavior point, where
a sudden shift occurs between low levels of bystander
isomer depletion to high levels of bystander depletion. If
tu is decreased progressively from a long bystander resi-
dence time tu>tuþ , the system will remain on the outbreak
branch, even as tu is reduced below the threshold behavior
point through the region where the two steady-state
branches coexist. The system will exhibit a discontinuous
change in the steady state from the outbreak branch to the
fast flow branch at tu . We call this critical point the
bystander-isomer-rescue point because the bystander-
isomer-concentration level increases from this point as tu
decreases. The existence of two different critical points (to
change between steady-state branches) as we progressively
vary a parameter shows that our model exhibits hysteresis.
Interestingly, the model also exhibits hysteresis for
progressive variations of the ratio of basal misfolded isomer
to bystander isomer inflow rates l into the ER. Although we
cannot determine analytically a closed-form solution for the
critical l5 points, we know that the variation of l produces
a discontinuity in the number of the steady states from one
A Model of Threshold Behavior 1869to three, and back to one as we progressively increase l
(Fig. 2). Moreover, the l–x bifurcation diagram has a S-
shape curve similar to the tu–x bifurcation diagram shown
in Fig. 3 B, with both a threshold behavior point and the
bystander isomer rescue point.
Now we are in the position of investigating the effects of
both tu and l on the appearance of the threshold behavior.
There is a domain in the l–tu parameter plane where the
three physically realistic steady states of the model Eq. 11
exist and the threshold behavior will appear. This is shown
in Fig. 4. The analytical expression for the boundary curves
is given parametrically and implicitly by substituting Eq. 25
into Eq. 28. The two roots tu5 move closer together as l
increases. They intersect at the cusp point C, where
tu ¼ tuþ . The representation of the bistable area in the
l–tu parameter plane also confirms that the model exhibits
a hysteresis effect. Suppose that we have a fixed l between
the critical points l and lþ, and tu moves from zero verti-
cally. As the value of tu increases, the system will discontin-
uously jump from one steady state to three steady states
back to one steady state. The same discontinuous jump
can be observed for a fixed tu as l increases from zero hor-
izontally in Fig. 4.Necessary conditions for the threshold behavior
To this point, the analysis of our model shows that there are
three possible steady states for the extent of the reaction.
According to the parameter plane analysis (Fig. 4), the
threshold behavior is a function of tu and l. In reality, the
model can exhibit the threshold behavior if we guarantee
the existence of two physically realistic and distinct
tangency points. The conditions for the existence of two
realistic and distinct tangency points will provide us with0.025 0.05 0.075 0.1
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FIGURE 4 The threshold behavior depends on the nondimensional
bystander isomer residence time in the ER (tu) and basal misfolded
isomer/bystander isomer inflow rates into the ER (l). We illustrate this
result in the ltu parameter plane, which shows the number of physically
realistic steady states for the model from Eq. 17. The boundary curves are
given implicitly and parametrically by the solutions of Eq. 25 for n ¼ 1 and
m ¼ 2. At the cusp point C, l ¼ lþand tu ¼ tuþ . The model exhibits
three steady states inside the closed area, and one steady state outside.
(Inset) Figure detail.necessary conditions for the appearance of the threshold
behavior in our model. After careful examination of the
tangency point(s) given by Eq. 25, the model can have
two real and distinct tangency points if the discriminant D
is greater than zero:
D ¼ l2ðn 1Þ22lðnmþ nþ m 1Þ þ ðm 1Þ2>0:
(29)
As we discussed before, from the above inequality, the
model requires n R 1 and m R 2.
The analysis of Eq. 29 needs to be divided into two cases:
n ¼ 1 and nR 1. For the special case n ¼ 1, the l2 term is
eliminated from the discriminant D, which leads to the
necessary condition
l <
ðm 1Þ2
4m
: (30)
However, note that the condition (Eq. 20) for the model to
exhibit a physically realistic steady state when n ¼ 1,
l < m; (31)
is stronger than condition given by Eq. 30. Therefore, for the
special case n ¼ 1, Eq. 31 is a necessary condition for the
model to exhibit threshold behavior. For the more generic
case n > 1, we need to solve the quadratic expression of
Eq. 29. After some basic analysis, we find that the
expression
l <
mðnþ 1Þ þ ðn 1Þ  2 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃnmðnþ m 1Þp
ðn 1Þ2 (32)
is a necessary condition for the system to exhibit the
threshold behavior when n > 1. Equations 31 and 32 permit
us to assess the dependence of the threshold behavior on the
ratio of basal misfolded isomer to bystander isomer inflow
rates and the order of the reaction with respect to the mis-
folded isomer (Fig. 5). For a fixed value of l, there are reac-
tion order values that are favorable for the threshold
behavior, as well as reaction order values that will guarantee
monostability in the model. In the case that the reaction
order exponents are favorable for the appearance of bistabil-
ity, the threshold behavior will be exhibited if l and tu are
both in a parameter plane analysis region (Fig. 4) where
the model has three steady states.DISCUSSION
We presented a model of bystander and misfolded protein
interaction to investigate how the threshold behavior in
protein misfolding is triggered in conformational diseases.
In our model, bystander isomers are converted by the mis-
folded isomers through a process catalyzed by the misfolded
isomers with a phenomenological rate of the form Eq. 3. We
model the ER as a reactor with a continuous flow ofBiophysical Journal 100(8) 1864–1873
Am
λ
0.2
0.6
1.0
1.4
1.8
2 3 4 5 6 7 8 9
2
4
6
8
10
0
2
4
6
8
10
0
2
4
6
8
0
2
4
6
8
10
8
6
4
2
n m
λ
B
1 steady 
state
1 steady 
state
1 or 3 
steady 
states
1 or 3 
steady 
states
FIGURE 5 The order of the reaction with respect to the misfolding
isomer plays an important role in the appearance of the threshold behavior.
We illustrate this point by showing the number of steady states in the
parameter domain l–n–m for our model equation (Eq. 17). The domains
are defined by necessary conditions obtained from the solutions of the
inequality from Eq. 29 for cases n ¼ 1 and n > 1. (A) Equation 31 defines
the domains for one steady state, and one-or-three steady states for the
special case n¼ 1. (B) Equation 32 defines the same domains for one steady
state, and one-or-three steady states for the case n> 1. The panels show that
there are reaction order exponents which are favorable for the appearance of
the threshold behavior for a fixed value of l.
1870 Sandefur and Schnellbystander and misfolded isomers (Fig. 1), which is the direct
result of basal protein synthesis and depletion. Conforma-
tional disease can either result from a dominant-negative
effect of misfolded isomers, leading to a loss-of-function
of the native folded protein, or from a toxic gain-of-function
of the misfolded isomer. Interestingly we can investigate
both loss-of-function and toxic gain-of-function diseases
by modeling the extent of the overall reaction between
bystander and misfolded isomers.
Previous studies (16–19) showed that the threshold
behavior in conformational diseases is caused by the
nonlinear phenomenon known as bistability. Our mathemat-
ical model also displayed bistability, though it is qualita-
tively different from the other models. In Rieger et al.
(16), protein misfolding and aggregation are regulated by
folding chaperones. In our model, protein misfolding cannot
be reversed by folding chaperones. The other models
(17–19) focus on the quantification of prion infection
dynamics. We do not investigate the role of protein misfold-
ing in infection by prions.
In our model, there are three possible steady states; two of
these steady states are stable to small perturbations and are
easily observable under physiological conditions.The stableBiophysical Journal 100(8) 1864–1873steady state with the lower bystander isomer depletion and
lower misfolded production is characterized by the fast
flow of bystander isomers in the ER lumen. On the other
hand, the stable steady state with the higher bystander deple-
tion and higher misfolded production causes the outbreak of
the conformational disease (Fig. 3). Our analysis showed
that the appearance of the threshold behavior depends on
two parameters: the ratio of basal misfolded isomer to
bystander isomer inflow rates l, and the bystander isomer
residence time tu (Fig. 4). These parameters are external
to the misfolding reaction mechanism, because they are
driven by the ER protein production, folding, and export
machinery. We also found that there are values of the order
of the reaction with respect to the misfolded isomer that
favor the appearance of the threshold behavior (Fig. 5).
This reaction order is an internal property of the reaction
mechanism, because it can depend specifically on the nature
of the elementary reactions driving protein misfolding.
The appearance of bistability has important implications
for the onset and rescue of conformational diseases.What are the factors that can cause the outbreak
of protein misfolding in conformational
diseases?
Here we must relate the parameters controlling the appear-
ance of bistability to the steady-state values of the model
x* shown in Fig. 6. A low x* implies a high bystander
isomer concentration (and a low misfolded isomer produc-
tion) at steady state, while a high x* implies a low bystander
isomer concentration (and high misfolded isomer produc-
tion) at steady state. An outbreak of misfolding isomer
production can be the result of increasing the transition
time of the bystander protein in the ER (Fig. 6 A, control
versus tu¼ 1.5) above the threshold behavior point. Current
experimental evidence supports this observation. An in-
crease in the bystander proinsulin transition time in the
Akita mice results in Mutant INS-gene Induced Diabetes
of Youth (5,6).
Alternatively, depletion of bystander protein will reach a
loss-of-function point if we increase the ratio of basal
misfolded isomer to bystander isomer inflow rates in the
ER (Fig. 6 A, control versus l ¼ 0.13) above the threshold
point. This ratio can be increased by overexpression of the
basal misfolded isomer levels. There is experimental
evidence to support this model prediction. In the Akita
mouse, higher levels of misfolded proinsulin results in
fulminant diabetes within two weeks of life (40) and in
a reduction of bystander insulin (6). Similar results have
been reported for the toxicity of Dutch E22Q and Flemish
A21G mutant amyloid b proteins in human cerebral micro-
vessel and aortic smooth muscle cells (9). Interestingly, our
model predicts that an increase of the order of the misfolded
isomer can trigger the outbreak in misfolding isomer
production and the depletion of bystander protein (Fig. 6 A,
Control Disease
RescueDisease
τ = 1
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τ = 0
.03
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FIGURE 6 Parameters involved in the onset and rescue of conforma-
tional diseases. A low x* implies a high bystander isomer concentration
at steady state, while a high x* implies a low bystander isomer concentra-
tion at steady state. (A) Here, we illustrate how the onset of conformational
disease can be caused by increasing the transition time of the bystander
protein in the ER (tu), basal misfolded isomer/bystander isomer inflow rates
in the ER (l), or the misfolded isomer reaction order (m). Parameter values
for control: tu ¼ 0.45, l ¼ 0.025, n ¼ 4, and m ¼ 4. (B) Bystander protein
concentration is rescued by decreasing tu, l, or m. Parameter values for
disease are tu ¼ 0.10, l ¼ 0.1875, n ¼ 4, and m ¼ 5.
A Model of Threshold Behavior 1871control versus m ¼ 5). This reaction order exponent will
increase if the number of misfolded isomers involved in
the recruitment of bystander proteins into aberrant isomer
complexes increases. More work is needed to characterize,
precisely, the reaction mechanisms involved in the recruit-ment of bystander proteins into misfolded isomer
complexes.From the disease rescue point of view,
what can be done to rescue bystander isomers
or decrease misfolded isomer production?
A general increase in the folding capacity of the ER can
reduce the bystander isomer residence time (41), resulting
in the rescue of bystander protein (Fig. 6 B, disease versus
tu ¼ 0.03). Rieger et al. (16) proposed that the overexpres-
sion of molecular chaperones can increase folding capacity,
reducing protein misfolding and aggregation in neurodegen-
erative diseases. Of course, the ability to rescue bystander
protein by decreasing the bystander residence time will
likely depend on the specific nature of the protein itself,
which will in turn influence the folding and trafficking
pathways accessible to the protein (42).
Alternatively, bystander proteins can be rescued by
decreasing the ratio of basal misfolded isomer to bystander
isomer inflow rates in the ER (Fig. 6 B, disease versus l ¼
0.063). This ratio can be decreased by the upregulation of
basal isomer inflow or downregulation of the basal misfolded
isomer inflow. This rescue mechanism can be tested by
increasing the expressionof the bystander isomerwith varying
levels and verifying that rescue is not caused by a general
increase in folding capacity of the ER. Another strategy for
rescuing from the conformational disease is to reduce the reac-
tion order of the misfolded isomer (Fig. 6 B, disease versus
m ¼ 3). The reduction of reaction order m can be achieved
through the introduction of pharmacological inhibitors, which
block elementary reactions involving the association of mis-
folded isomers into complexes. Pharmacological agents can
also affect tu by changing the reaction coefficient k.
The above potential therapies must account for the hyster-
esis in bistable systems. The rescue of the system to the high
bystander concentration (or low misfolded isomer produc-
tion) requires a decrease of tu, l, and m below the threshold
point level to overcome the hysteresis phenomena due to
bistability.CONCLUDING REMARKS
Our model proposes qualitative ideas for the rescue of
conformational diseases. It is not easy to determine an
optimal strategy quantitatively, particularly because the
specific nature of the protein and its misfolding pathway
must be taken into account. Therefore, a more detailed
description of the bystander and misfolded protein reaction
mechanism and their interactions with the ER machinery is
required. The modeling of these detailed mechanisms will
allow us to investigate the control of the threshold behavior
and to develop a more complete and quantitative theory for
the design of rescue strategies for specific conformational
diseases.Biophysical Journal 100(8) 1864–1873
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The shape of yr(x)
To distinguish between unique and multiple steady states, we need to under-
stand the shape of yr(x) for x ¼ [0,1]. The equation of yr(x) is a (nþm)th
order polynomial of the form
yrðxÞ ¼ ð1 xÞnðtrx þ qÞm: (33)
First, we proceed to calculate the critical points of Eq. 33 by determining
the values of x for which the derivative of Eq. 33 with respect to x is equal
to zero. This becomes
y0rðxÞ ¼ ½mtrð1xÞ  nðtrx þ qÞð1 xÞðn1Þðtrx þ qÞðm1Þ
¼ 0:
(34)
The critical values satisfying the above equation arex ¼

 q
tr
; 1 nðtr þ qÞ
trðnþ mÞ; 1

: (35)
Using the second derivative test, we determine that the function yr(x) is
concave downward and has a maximum at the critical point x ¼ 1n
(tr þ q)/tr (nþm):
y00r

x ¼ 1 nðtr þ qÞ
trðnþ mÞ
	
<0: (36)
The maximum value is, therefore,
yrðxÞmax¼

nðtr þ qÞ
trðnþ mÞ
	n
mðtr þ qÞ
nþ m
	m
: (37)
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